Company Overview
ThinkSono is the developer of the world's first ultrasound AI for blood clot (DVT) detection. Their innovative AI-guided ultrasound technology allows any healthcare professional, even without ultrasound training, to perform blood clot scans with ease and accuracy at the point of care. This helps reduce waiting times and negative DVT cases, streamlining clinical pathways and improving patient outcomes.
Products and Benefits
ThinkSono's guidance system facilitates rapid and effective DVT exams using real-time AI to guide correct anatomy identification and positioning. The technology transforms a process that typically takes several hours into one that can be completed in just 15 minutes, empowering healthcare teams to conduct point-of-care assessments efficiently.
Their software is CE Class IIb marked for clinical use in the EU and UK, with registrations including EUDAMED and MHRA. ThinkSono Guidance is designed to be easily implemented within 24 hours, saving valuable time for both healthcare providers and patients.
Trust and Validation
More than 1,000 patients have been scanned in rigorous, multi-centered clinical trials across the UK and EU. Esteemed medical professionals from leading institutions have endorsed the software's efficacy and potential to revolutionize DVT diagnostic pathways.
Contact and Social Links
Twitter: @thinksono